These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7376831

  • 1. Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilization.
    Brooks SE, Hoffman LM, Adachi M, Amsterdam D, Schneck L.
    Acta Neuropathol; 1980; 50(1):9-17. PubMed ID: 7376831
    [Abstract] [Full Text] [Related]

  • 2. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L.
    J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hexosaminidase C in brain affected by Tay-Sachs Disease.
    Minami R, Nakamura F, Oyanagi K, Nakao T.
    Tohoku J Exp Med; 1981 Feb; 133(2):175-85. PubMed ID: 7268761
    [Abstract] [Full Text] [Related]

  • 7. Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells.
    Igdoura SA, Mertineit C, Trasler JM, Gravel RA.
    Hum Mol Genet; 1999 Jun; 8(6):1111-6. PubMed ID: 10332044
    [Abstract] [Full Text] [Related]

  • 8. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS, Krusell A, Krusell J, Lyerla TA, Kolodny EH.
    Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
    [Abstract] [Full Text] [Related]

  • 9. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
    Matsuoka K, Tamura T, Tsuji D, Dohzono Y, Kitakaze K, Ohno K, Saito S, Sakuraba H, Itoh K.
    Mol Ther; 2011 Jun 15; 19(6):1017-24. PubMed ID: 21487393
    [Abstract] [Full Text] [Related]

  • 11. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K.
    Clin Chim Acta; 1983 Nov 30; 135(1):89-93. PubMed ID: 6228344
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
    Meier EM, Schwarzmann G, Fürst W, Sandhoff K.
    J Biol Chem; 1991 Jan 25; 266(3):1879-87. PubMed ID: 1824846
    [Abstract] [Full Text] [Related]

  • 16. Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and control.
    Brooks SE, Amsterdam D, Hoffman LM, Adachi M, Schneck L.
    J Cell Sci; 1979 Aug 25; 38():211-23. PubMed ID: 230195
    [Abstract] [Full Text] [Related]

  • 17. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
    Navon R, Kopel R, Nutman J, Frisch A, Conzelmann E, Sandhoff K, Adam A.
    Am J Hum Genet; 1985 Jan 25; 37(1):138-46. PubMed ID: 3156493
    [Abstract] [Full Text] [Related]

  • 18. Enzyme replacement in Tay-Sachs disease.
    von Specht BU, Geiger B, Arnon R, Passwell J, Keren G, Goldman B, Padeh B.
    Neurology; 1979 Jun 25; 29(6):848-54. PubMed ID: 572006
    [Abstract] [Full Text] [Related]

  • 19. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E, Kytzia HJ, Navon R, Sandhoff K.
    Am J Hum Genet; 1983 Sep 25; 35(5):900-13. PubMed ID: 6614006
    [Abstract] [Full Text] [Related]

  • 20. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
    Hoffman LM, Brooks SE, Stein MR, Adachi M, Schneck L.
    Metab Brain Dis; 1989 Jun 25; 4(2):87-93. PubMed ID: 2547146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.